ALKEMUpdated 29 Aug 2026, 2:19

Alkem Laboratories Ltd.

ALKEMUpdated 29 Aug 2026, 2:19

Market Cap

₹64,095Cr.

Current Price

₹5,355

High / Low

₹5,934/5,075

Stock P/E

28.6

ROE18.2%

ROCE19.9%

Book Value₹1,171

Face Value₹2.00

Dividend Yield0.99%

About

Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	45	45	51	60	62	85	79	73	71	80	65	59
Inventory Days	143	139	175	180	159	156	207	202	164	257	196	212
Days Payable	90	110	139	144	121	116	131	114	103	219	188	192
Cash Conversion Cycle	97	74	86	97	100	125	155	162	133	119	72	79
Working Capital Days	-62	12	29	43	51	39	45	13	50	171	128	123
ROCE %	11%	22%	21%	19%	17%	20%	23%	18%	13%	16%	20%	20%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 29 August 2026 at 2:19

ALKEM LABORATORIES LTD. (ALKEM) financials — quarterly results, P&L, cash flow, balance sheet, shareholding